Novavax

Novavax looks to expand Covid-19 vaccine authorisation  

8 July 2022

Pharmaceutical company Novavax is attempting to expand the use of its Covid-19 vaccine Nuvaxovid into adolescents aged 12-17 year and as a booster dose for adults.   The company has submitted a request to Swissmedic to expand the conditional marketing authorisation (CMA) of Nuvaxovid. The request is based on data from the company’s ongoing PREVENT-19 Phase […]

Serum Institute of India enters adolescents Covid-19 vaccine market  

29 March 2022

The recent approval of Novavax’s protein-based Covid-19 vaccine for adolescents aged 12-18 years will help its partner, the Serum Institute of India (SII) enter the adolescents’ market, according to GlobalData.   Novavax’s Covid-19 vaccine was granted emergency use authorisation by the Drugs Controller General of India (DCGI) in March for adolescents aged 12-18 years. Novavax’s partner, […]